China Precision Medicine Business Opportunities Databook 2023: Focus on Mepolizumab, Osimertinib, Aripiprazole Lauroxil, & Alectinib - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jul 13, 2023--
Source: galvnews.com
On Premise Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from On Premise Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In On Premise Platform Today - Breaking & Trending Today
China Precision Medicine Business Opportunities Databook 2023: Focus on Mepolizumab, Osimertinib, Ar
DUBLIN--(BUSINESS WIRE)--The "China Precision Medicine Business Opportunities Databook - Q2 2023 Update" report has been added to ResearchAndMarkets.com's offering.China's precision medicine market size is expected to record a CAGR of 13% during 2023-2027 to reach US$6.403 billion by 2027, increasing from US$3.92 bi...
Source: pharmiweb.com